A detailed history of Intech Investment Management LLC transactions in Harrow Health, Inc. stock. As of the latest transaction made, Intech Investment Management LLC holds 22,594 shares of HROW stock, worth $654,096. This represents 0.01% of its overall portfolio holdings.

Number of Shares
22,594
Previous 10,236 120.73%
Holding current value
$654,096
Previous $460,000 64.78%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 10, 2025

BUY
$33.39 - $57.5 $412,633 - $710,585
12,358 Added 120.73%
22,594 $758,000
Q3 2024

Nov 08, 2024

BUY
$20.85 - $46.47 $213,420 - $475,666
10,236 New
10,236 $460,000

Others Institutions Holding HROW

About HARROW HEALTH, INC.


  • Ticker HROW
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 27,070,000
  • Market Cap $784M
  • Description
  • Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...
More about HROW
Track This Portfolio

Track Intech Investment Management LLC Portfolio

Follow Intech Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intech Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intech Investment Management LLC with notifications on news.